Early pregnancy factor (EPF), identified as an immunosuppresive protein, can be detected in maternal serum within 6-24 hours of fertilization and is present for at least the first two trimester of pregnancy. Besides pregnancy, EPF is secreted by tumor cells, normal growing cells and active platelets during cell growth and division. It is also required for tumor proliferation and tissue renewal. Seventy per cent of the amino acid sequence of EPF derived from human platelets was determined and except from a single residue, it was identical to the sequence of rat mitochondrial chaperonin 10 (cpn 10). The molecular weight of the protein was found to be 10,843 Da. Whether EPF and cpn 10 are the same molecule or not is still discussed by many researchers. The rosette inhibition test (RIT) which is the most widely used and most reliable assay for EPF detection is not practical for routine utilization since it is laborious, time consuming and sensitive. Recently, it is expected to speed up the EPF studies by investigating novel assay systems that will be more practical than RIT.